<!DOCTYPE html>
<html lang="en">
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1.0" charset="UTF-8">
    <title>Makiko Wholey / CUNY Graduate School of Journalism</title>
    <!--<link href="https://fonts.googleapis.com/css?family=Baloo+Da|Domine|Creepster" rel="stylesheet">-->
  <link rel="stylesheet" type="text/css" href="css/mushroom.css">
</head>
  <body>

    <!-- page content here-->
    <!--page header-->
    <header>
    	<p><h1 align="center">Mushroom Therapy: Measuring the Efficacy of Psilocybin on Johns Hopkins Palliative Cancer Patients
 
 </h1></p>

    	<!--byline here-->

    	<h2 align="center"><a href="https://twitter.com/MakikoWholey">By Makiko Wholey</a></h2>

    	<!--image here-->


    	<figure>
      <center>
        <img src="images/mushroom.jpg" style="width:500px;height:500px;">
        <figcaption>
          <p class="center">Psilocybin mushrooms. Photo by Damion Orion</p>
        </figcaption>
    	</center>
      </figure>

    </header>

    <!--news story text below-->
<div id="text">

  <section class="story">

  <p>Medical research on psilocybin, a psychedelic compound in mushrooms, stopped in the U.S. in the 1960s after rampant criminal recreational use raised concerns about safety and influenced general perception. In recent years there’s been a resurgence in research on psilocybin’s therapeutic potential and the results have been surprisingly favorable. Johns Hopkins completed a study this year on 56 patients with life-threatening cancer and a DSM-IV diagnosis of anxiety and depressive mood symptoms. Cancer patients with these symptoms have been associated with a decreased quality of life and increased suicidality. Patients who are anxious and depressed also often do not adhere to recommended treatment.  The outcome of the Johns Hopkins study demonstrated the effectiveness of psilocybin to decrease depression and anxiety and increase the quality of life in patients with life-threatening cancer. The below chart illustrates the patients positive/negative emotions and existential feelings following a low dose (placebo level) and high dose of psilocybin. 
 </p>

  <!--chart below-->

<iframe id="datawrapper-chart-InOPB" src="https://datawrapper.dwcdn.net/InOPB/3/" frameborder="0" allowtransparency="true" allowfullscreen="allowfullscreen" webkitallowfullscreen="webkitallowfullscreen" mozallowfullscreen="mozallowfullscreen" oallowfullscreen="oallowfullscreen" msallowfullscreen="msallowfullscreen" width="100%" height="782"></iframe><script type="text/javascript">if("undefined"==typeof window.datawrapper)window.datawrapper={};window.datawrapper["InOPB"]={},window.datawrapper["InOPB"].embedDeltas={"100":1002,"200":870,"300":826,"400":799,"500":782,"600":782,"700":755,"800":755,"900":755,"1000":755},window.datawrapper["InOPB"].iframe=document.getElementById("datawrapper-chart-InOPB"),window.datawrapper["InOPB"].iframe.style.height=window.datawrapper["InOPB"].embedDeltas[Math.min(1e3,Math.max(100*Math.floor(window.datawrapper["InOPB"].iframe.offsetWidth/100),100))]+"px",window.addEventListener("message",function(a){if("undefined"!=typeof a.data["datawrapper-height"])for(var b in a.data["datawrapper-height"])if("InOPB"==b)window.datawrapper["InOPB"].iframe.style.height=a.data["datawrapper-height"][b]+"px"});</script>
    </section>
    </div>

   </footer> 
  </div>
    
  </body>
</html>